BioLineRx Ltd.
A clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases.
BLRX | TA
Overview
Corporate Details
- ISIN(s):
- US09071M2052 (+1 more)
- LEI:
- 529900AKIOSC15Y63R18
- Country:
- Israel
- Address:
- Modi'in Technology Park, 2 HaMa'ayan Street, 7177871 Modi'in
- Website:
- https://www.biolinerx.com/
- Sector:
- Manufacturing
Description
BioLineRx Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for oncology and rare diseases. The company leverages its drug development capabilities to advance novel, early-stage therapeutic candidates through the clinical development process toward regulatory approval. Its pipeline consists of treatments, including small molecules, designed to address unmet medical needs and deliver meaningful benefits to patients. BioLineRx also partners with other drug developers to advance their early-stage programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-11-15 09:33 |
PROSPECTUS SUPPLEMENT-Up to $4,430,000 of American Depositary Shares Representi…
|
English | 35.9 KB | ||
| 2020-10-30 13:49 |
Announces Positive Results from Interim Analysis of GENESIS Phase 3 Trial of Mo…
|
English | 116.2 KB | ||
| 2020-10-30 13:49 |
Announces Positive Results from Interim Analysis of GENESIS Phase 3 Trial of Mo…
|
English | 36.1 KB | ||
| 2020-10-29 16:01 |
BioLineRx Announces Initiation of Phase 2 Clinical Trial
in First-Line Metasta…
|
English | 72.8 KB | ||
| 2020-10-29 16:01 |
BioLineRx Announces Initiation of Phase 2 Clinical Trial
in First-Line Metasta…
|
English | 36.0 KB | ||
| 2020-09-27 10:37 |
PROSPECTUS SUPPLEMENT - ATM
|
English | 495.2 KB | ||
| 2020-09-27 10:37 |
PROSPECTUS SUPPLEMENT - ATM
|
English | 35.9 KB | ||
| 2020-09-27 10:35 |
enters into At-The-Market Agreement with H.C. Wainwright & Co., LLC
|
English | 206.9 KB | ||
| 2020-09-27 10:35 |
enters into At-The-Market Agreement with H.C. Wainwright & Co., LLC
|
English | 35.9 KB | ||
| 2020-09-25 01:19 |
reports results of shareholders meeting
|
English | 170.4 KB | ||
| 2020-09-25 01:19 |
reports results of shareholders meeting
|
English | 35.9 KB | ||
| 2020-08-20 02:12 |
ANNUAL GENERAL MEETING OF SHAREHOLDERS to be held
ON SEPTEMBER 24, 2020
|
English | 174.1 KB | ||
| 2020-08-20 02:12 |
ANNUAL GENERAL MEETING OF SHAREHOLDERS to be held
ON SEPTEMBER 24, 2020
|
English | 240.3 KB | ||
| 2020-08-20 02:12 |
ANNUAL GENERAL MEETING OF SHAREHOLDERS to be held
ON SEPTEMBER 24, 2020
|
English | 125.4 KB | ||
| 2020-08-19 16:24 |
BioLineRx Achieves Enrollment Target in Phase 3 GENESIS Trial for Planned Inter…
|
English | 202.8 KB |
Automate Your Workflow. Get a real-time feed of all BioLineRx Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioLineRx Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioLineRx Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
